These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30223388)

  • 21. The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.
    Zhang X; Lu L; Shang Y; Liu P; Wei Y; Ma L; Gong P
    Int J Surg; 2017 Dec; 48():142-148. PubMed ID: 29107188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin α7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.
    Bai X; Gao C; Zhang L; Yang S
    J Clin Lab Anal; 2019 Oct; 33(8):e22979. PubMed ID: 31325216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
    Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
    BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.
    Cui Y; Niu M; Zhang X; Zhong Z; Wang J; Pang D
    Tumour Biol; 2015 Dec; 36(12):9919-27. PubMed ID: 26168958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
    Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features of triple-negative breast cancer in Taiwanese women.
    Yao-Lung K; Dar-Ren C; Tsai-Wang C
    Int J Clin Oncol; 2011 Oct; 16(5):500-5. PubMed ID: 21455625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
    Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
    Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
    World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.
    Dietrich D; Krispin M; Dietrich J; Fassbender A; Lewin J; Harbeck N; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Spyratos F; Foekens JA; Lesche R; Martens JW
    BMC Cancer; 2010 Jun; 10():247. PubMed ID: 20515469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.